

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 6.75950465 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.75950465 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 6.46605667 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.46605667 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.12702812 |
| 6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.98648753 |
| 7 | neutrophil activation involved in immune response (GO:0002283) | 5.62509752 |
| 8 | indole-containing compound catabolic process (GO:0042436) | 5.57659092 |
| 9 | indolalkylamine catabolic process (GO:0046218) | 5.57659092 |
| 10 | tryptophan catabolic process (GO:0006569) | 5.57659092 |
| 11 | alpha-linolenic acid metabolic process (GO:0036109) | 5.55004950 |
| 12 | complement activation, alternative pathway (GO:0006957) | 5.50748011 |
| 13 | urea metabolic process (GO:0019627) | 5.48353860 |
| 14 | urea cycle (GO:0000050) | 5.48353860 |
| 15 | kynurenine metabolic process (GO:0070189) | 5.47001543 |
| 16 | bile acid biosynthetic process (GO:0006699) | 5.45935266 |
| 17 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.31262036 |
| 18 | protein carboxylation (GO:0018214) | 5.31262036 |
| 19 | negative regulation of fibrinolysis (GO:0051918) | 5.28743677 |
| 20 | glyoxylate metabolic process (GO:0046487) | 5.26858992 |
| 21 | high-density lipoprotein particle remodeling (GO:0034375) | 5.26603133 |
| 22 | tryptophan metabolic process (GO:0006568) | 5.24402831 |
| 23 | regulation of protein activation cascade (GO:2000257) | 5.17885539 |
| 24 | sulfur amino acid catabolic process (GO:0000098) | 5.09495910 |
| 25 | nitrogen cycle metabolic process (GO:0071941) | 5.03737410 |
| 26 | regulation of fibrinolysis (GO:0051917) | 5.02497533 |
| 27 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.95529687 |
| 28 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.95529687 |
| 29 | modulation by symbiont of host immune response (GO:0052553) | 4.95529687 |
| 30 | positive regulation by symbiont of host defense response (GO:0052509) | 4.95529687 |
| 31 | modulation by symbiont of host defense response (GO:0052031) | 4.95529687 |
| 32 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.95529687 |
| 33 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.94589242 |
| 34 | regulation of triglyceride catabolic process (GO:0010896) | 4.92574882 |
| 35 | response to peptidoglycan (GO:0032494) | 4.91247451 |
| 36 | regulation of complement activation (GO:0030449) | 4.88162617 |
| 37 | cysteine metabolic process (GO:0006534) | 4.87048935 |
| 38 | detection of molecule of bacterial origin (GO:0032490) | 4.76467027 |
| 39 | reverse cholesterol transport (GO:0043691) | 4.68404220 |
| 40 | bile acid metabolic process (GO:0008206) | 4.65135242 |
| 41 | protein-lipid complex remodeling (GO:0034368) | 4.64815127 |
| 42 | macromolecular complex remodeling (GO:0034367) | 4.64815127 |
| 43 | plasma lipoprotein particle remodeling (GO:0034369) | 4.64815127 |
| 44 | plasma lipoprotein particle clearance (GO:0034381) | 4.56049053 |
| 45 | serine family amino acid catabolic process (GO:0009071) | 4.55560734 |
| 46 | regulation of cholesterol esterification (GO:0010872) | 4.51517175 |
| 47 | phospholipid efflux (GO:0033700) | 4.49149293 |
| 48 | detection of other organism (GO:0098543) | 4.49004419 |
| 49 | aromatic amino acid family metabolic process (GO:0009072) | 4.41474520 |
| 50 | amino-acid betaine metabolic process (GO:0006577) | 4.40530798 |
| 51 | triglyceride homeostasis (GO:0070328) | 4.39849738 |
| 52 | acylglycerol homeostasis (GO:0055090) | 4.39849738 |
| 53 | leukocyte migration involved in inflammatory response (GO:0002523) | 4.34398567 |
| 54 | tyrosine metabolic process (GO:0006570) | 4.31053476 |
| 55 | detection of external biotic stimulus (GO:0098581) | 4.29233797 |
| 56 | lysine catabolic process (GO:0006554) | 4.28422942 |
| 57 | lysine metabolic process (GO:0006553) | 4.28422942 |
| 58 | homocysteine metabolic process (GO:0050667) | 4.28008962 |
| 59 | alpha-amino acid catabolic process (GO:1901606) | 4.18974189 |
| 60 | negative regulation of sterol transport (GO:0032372) | 4.16611694 |
| 61 | negative regulation of cholesterol transport (GO:0032375) | 4.16611694 |
| 62 | imidazole-containing compound metabolic process (GO:0052803) | 4.15596535 |
| 63 | macrophage activation involved in immune response (GO:0002281) | 4.11963436 |
| 64 | detection of bacterium (GO:0016045) | 4.09861854 |
| 65 | ethanol oxidation (GO:0006069) | 4.04238726 |
| 66 | cholesterol efflux (GO:0033344) | 4.02058572 |
| 67 | bile acid and bile salt transport (GO:0015721) | 4.01305683 |
| 68 | phospholipid homeostasis (GO:0055091) | 4.00042950 |
| 69 | plasma lipoprotein particle assembly (GO:0034377) | 3.99524095 |
| 70 | low-density lipoprotein particle remodeling (GO:0034374) | 3.95507301 |
| 71 | cellular extravasation (GO:0045123) | 3.94712624 |
| 72 | positive regulation of lipid catabolic process (GO:0050996) | 3.94600217 |
| 73 | neutrophil activation (GO:0042119) | 3.92622853 |
| 74 | indolalkylamine metabolic process (GO:0006586) | 3.91399233 |
| 75 | cellular glucuronidation (GO:0052695) | 3.90255073 |
| 76 | glycine metabolic process (GO:0006544) | 3.90102693 |
| 77 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.89470451 |
| 78 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.89470451 |
| 79 | cellular ketone body metabolic process (GO:0046950) | 3.87184338 |
| 80 | cellular amino acid catabolic process (GO:0009063) | 3.86584844 |
| 81 | coenzyme catabolic process (GO:0009109) | 3.85959549 |
| 82 | fibrinolysis (GO:0042730) | 3.84506564 |
| 83 | cellular biogenic amine catabolic process (GO:0042402) | 3.82026333 |
| 84 | amine catabolic process (GO:0009310) | 3.82026333 |
| 85 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.81898320 |
| 86 | benzene-containing compound metabolic process (GO:0042537) | 3.76213543 |
| 87 | aldehyde catabolic process (GO:0046185) | 3.76175990 |
| 88 | detection of biotic stimulus (GO:0009595) | 3.75679800 |
| 89 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.73743061 |
| 90 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.73743061 |
| 91 | arginine metabolic process (GO:0006525) | 3.72299595 |
| 92 | complement activation (GO:0006956) | 3.71471675 |
| 93 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.71435491 |
| 94 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.71204288 |
| 95 | regulation of mast cell degranulation (GO:0043304) | 3.70170740 |
| 96 | serine family amino acid metabolic process (GO:0009069) | 3.69340007 |
| 97 | acetyl-CoA metabolic process (GO:0006084) | 3.69171142 |
| 98 | plasma lipoprotein particle organization (GO:0071827) | 3.68559116 |
| 99 | negative regulation of cell killing (GO:0031342) | 3.67922393 |
| 100 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.67922393 |
| 101 | protein activation cascade (GO:0072376) | 3.66859475 |
| 102 | glutamate metabolic process (GO:0006536) | 3.66571854 |
| 103 | negative regulation of interleukin-12 production (GO:0032695) | 3.65068153 |
| 104 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.64897319 |
| 105 | granulocyte activation (GO:0036230) | 3.64502344 |
| 106 | complement activation, classical pathway (GO:0006958) | 3.63144537 |
| 107 | cellular modified amino acid catabolic process (GO:0042219) | 3.61794495 |
| 108 | blood coagulation, intrinsic pathway (GO:0007597) | 3.61637246 |
| 109 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.60536041 |
| 110 | cholesterol homeostasis (GO:0042632) | 3.60345804 |
| 111 | protein-lipid complex assembly (GO:0065005) | 3.59419980 |
| 112 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.58230432 |
| 113 | negative regulation of lipase activity (GO:0060192) | 3.56738260 |
| 114 | regulation of leukocyte degranulation (GO:0043300) | 3.55677332 |
| 115 | sterol homeostasis (GO:0055092) | 3.54182265 |
| 116 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.52622835 |
| 117 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.52537578 |
| 118 | opsonization (GO:0008228) | 3.51794603 |
| 119 | carboxylic acid catabolic process (GO:0046395) | 3.50649563 |
| 120 | organic acid catabolic process (GO:0016054) | 3.50649563 |
| 121 | cofactor catabolic process (GO:0051187) | 3.50515024 |
| 122 | low-density lipoprotein particle clearance (GO:0034383) | 3.50235983 |
| 123 | fatty acid oxidation (GO:0019395) | 3.49950072 |
| 124 | fatty acid beta-oxidation (GO:0006635) | 3.49096727 |
| 125 | response to host immune response (GO:0052572) | 3.47974304 |
| 126 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.47974304 |
| 127 | protein-lipid complex subunit organization (GO:0071825) | 3.47270597 |
| 128 | serine family amino acid biosynthetic process (GO:0009070) | 3.46986284 |
| 129 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.46711508 |
| 130 | glucuronate metabolic process (GO:0019585) | 3.46245055 |
| 131 | uronic acid metabolic process (GO:0006063) | 3.46245055 |
| 132 | short-chain fatty acid metabolic process (GO:0046459) | 3.45055913 |
| 133 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.43837522 |
| 134 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.42993465 |
| 135 | leukocyte aggregation (GO:0070486) | 3.41917711 |
| 136 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.40092970 |
| 137 | response to host (GO:0075136) | 3.39348716 |
| 138 | response to host defenses (GO:0052200) | 3.39348716 |
| 139 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.39348716 |
| 140 | respiratory burst (GO:0045730) | 3.29580308 |
| 141 | microglial cell activation (GO:0001774) | 3.29338742 |
| 142 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.27943110 |
| 143 | positive regulation of mast cell activation (GO:0033005) | 3.17663854 |
| 144 | myeloid cell activation involved in immune response (GO:0002275) | 3.17306325 |
| 145 | macrophage activation (GO:0042116) | 3.16859620 |
| 146 | positive regulation of leukocyte degranulation (GO:0043302) | 3.13882010 |
| 147 | pinocytosis (GO:0006907) | 3.11334942 |
| 148 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.07704926 |
| 149 | regulation of superoxide anion generation (GO:0032928) | 3.07646601 |
| 150 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.05907050 |
| 151 | positive regulation of mast cell degranulation (GO:0043306) | 3.03701029 |
| 152 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.03701029 |
| 153 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.01009221 |
| 154 | hypotonic response (GO:0006971) | 2.97290984 |
| 155 | neutrophil mediated immunity (GO:0002446) | 2.96714807 |
| 156 | immunoglobulin mediated immune response (GO:0016064) | 2.90339523 |
| 157 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.88007997 |
| 158 | regulation of mast cell activation (GO:0033003) | 2.87253616 |
| 159 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.87219230 |
| 160 | pentose-phosphate shunt (GO:0006098) | 2.85806186 |
| 161 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.85759933 |
| 162 | response to muramyl dipeptide (GO:0032495) | 2.82028420 |
| 163 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.80718745 |
| 164 | regulation of regulated secretory pathway (GO:1903305) | 2.80691325 |
| 165 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.77979245 |
| 166 | leukocyte degranulation (GO:0043299) | 2.76650730 |
| 167 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.75611276 |
| 168 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.71219648 |
| 169 | protein localization to endosome (GO:0036010) | 2.66423363 |
| 170 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.66273612 |
| 171 | positive regulation of regulated secretory pathway (GO:1903307) | 2.66038320 |
| 172 | negative regulation of phagocytosis (GO:0050765) | 2.61895318 |
| 173 | hemidesmosome assembly (GO:0031581) | 2.60827587 |
| 174 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.58966085 |
| 175 | NADPH regeneration (GO:0006740) | 2.56379984 |
| 176 | barbed-end actin filament capping (GO:0051016) | 2.56111449 |
| 177 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.56026354 |
| 178 | positive regulation of interferon-alpha production (GO:0032727) | 2.55024784 |
| 179 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.53658227 |
| 180 | negative regulation of granulocyte differentiation (GO:0030853) | 2.52166022 |
| 181 | positive regulation of receptor recycling (GO:0001921) | 2.50369987 |
| 182 | negative regulation of interleukin-6 production (GO:0032715) | 2.49805845 |
| 183 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.49745944 |
| 184 | regulation of macrophage cytokine production (GO:0010935) | 2.47278623 |
| 185 | positive regulation of hemostasis (GO:1900048) | 2.44151765 |
| 186 | positive regulation of blood coagulation (GO:0030194) | 2.44151765 |
| 187 | B cell mediated immunity (GO:0019724) | 2.42940928 |
| 188 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.42673575 |
| 189 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.41199961 |
| 190 | lipoxygenase pathway (GO:0019372) | 2.40810033 |
| 191 | regulation of platelet aggregation (GO:0090330) | 2.39032190 |
| 192 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.37602055 |
| 193 | regulation of tolerance induction (GO:0002643) | 2.37601222 |
| 194 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.37542371 |
| 195 | macrophage differentiation (GO:0030225) | 2.37082647 |
| 196 | myeloid leukocyte activation (GO:0002274) | 2.36576479 |
| 197 | regulation of gamma-delta T cell activation (GO:0046643) | 2.36248536 |
| 198 | positive regulation of coagulation (GO:0050820) | 2.35941313 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.69247819 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.67676785 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.35024634 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.00765946 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.76665070 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.77907255 |
| 7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.76524279 |
| 8 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.75308867 |
| 9 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.61957170 |
| 10 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.34969259 |
| 11 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.66947322 |
| 12 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.60504019 |
| 13 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.37398988 |
| 14 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.25945760 |
| 15 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.19623614 |
| 16 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.06560791 |
| 17 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.9341415 |
| 18 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.95409276 |
| 19 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.93983864 |
| 20 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.93234856 |
| 21 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.90437433 |
| 22 | SPI1_23127762_ChIP-Seq_K562_Human | 1.88503171 |
| 23 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.88090982 |
| 24 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.85805678 |
| 25 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.81753068 |
| 26 | GATA1_22025678_ChIP-Seq_K562_Human | 1.70573115 |
| 27 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.69660592 |
| 28 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.69448330 |
| 29 | MYC_22102868_ChIP-Seq_BL_Human | 1.68656356 |
| 30 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.65745222 |
| 31 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.61445053 |
| 32 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.59184088 |
| 33 | MAF_26560356_Chip-Seq_TH1_Human | 1.58849873 |
| 34 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.58201135 |
| 35 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.57451726 |
| 36 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.56928386 |
| 37 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.56607314 |
| 38 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.55892300 |
| 39 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.53506113 |
| 40 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.50945993 |
| 41 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.49408804 |
| 42 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.48043438 |
| 43 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.46074919 |
| 44 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.45316520 |
| 45 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.43436084 |
| 46 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.43199140 |
| 47 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.41785407 |
| 48 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.39715865 |
| 49 | UTX_26944678_Chip-Seq_JUKART_Human | 1.39581186 |
| 50 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.33293520 |
| 51 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.30062623 |
| 52 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.28287846 |
| 53 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.24801253 |
| 54 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.24090002 |
| 55 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.23973043 |
| 56 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.23464735 |
| 57 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.22621089 |
| 58 | MYB_26560356_Chip-Seq_TH1_Human | 1.22419868 |
| 59 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.22385657 |
| 60 | MYB_26560356_Chip-Seq_TH2_Human | 1.21804115 |
| 61 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.19592842 |
| 62 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.19532355 |
| 63 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.18064444 |
| 64 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.17834616 |
| 65 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.17562787 |
| 66 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.17562787 |
| 67 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.16732937 |
| 68 | MAF_26560356_Chip-Seq_TH2_Human | 1.16375234 |
| 69 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.16038819 |
| 70 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.15421683 |
| 71 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.15365627 |
| 72 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.13158975 |
| 73 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.12171425 |
| 74 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.11825824 |
| 75 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.10556449 |
| 76 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.10518565 |
| 77 | ATF3_27146783_Chip-Seq_COLON_Human | 1.08761097 |
| 78 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.07140016 |
| 79 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.06807532 |
| 80 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.06272225 |
| 81 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.05110145 |
| 82 | * RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.05002587 |
| 83 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.03560960 |
| 84 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.03265711 |
| 85 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.01783716 |
| 86 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.01723504 |
| 87 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.01381772 |
| 88 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.99409378 |
| 89 | * KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.98274595 |
| 90 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.95685516 |
| 91 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.91908478 |
| 92 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.91170955 |
| 93 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.85120727 |
| 94 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.79978237 |
| 95 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.79176322 |
| 96 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.78609867 |
| 97 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.77457775 |
| 98 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.76460516 |
| 99 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.74061119 |
| 100 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.74029828 |
| 101 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.73894448 |
| 102 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.73644225 |
| 103 | GATA1_19941826_ChIP-Seq_K562_Human | 0.72277985 |
| 104 | GATA2_19941826_ChIP-Seq_K562_Human | 0.71633658 |
| 105 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.71462594 |
| 106 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.69409008 |
| 107 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.67509693 |
| 108 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.67297318 |
| 109 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.67267714 |
| 110 | * SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.66090029 |
| 111 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.64886079 |
| 112 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.63547625 |
| 113 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.63359162 |
| 114 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.63110564 |
| 115 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.62943121 |
| 116 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.62435573 |
| 117 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.62435573 |
| 118 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.62328734 |
| 119 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.61614097 |
| 120 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.61180709 |
| 121 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.60944774 |
| 122 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.60025199 |
| 123 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.59751364 |
| 124 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.59727361 |
| 125 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.59289112 |
| 126 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.58686324 |
| 127 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.57990006 |
| 128 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.57962440 |
| 129 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.57381988 |
| 130 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.57306670 |
| 131 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.57001296 |
| 132 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.55213347 |
| 133 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.54430461 |
| 134 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.54341891 |
| 135 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.53971169 |
| 136 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.53612420 |
| 137 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.53152767 |
| 138 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.52917900 |
| 139 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.52767466 |
| 140 | AR_20517297_ChIP-Seq_VCAP_Human | 0.52346863 |
| 141 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.51819252 |
| 142 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.51806972 |
| 143 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.51490653 |
| 144 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.50846214 |
| 145 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.49984288 |
| 146 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.49416343 |
| 147 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.49146141 |
| 148 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.48760187 |
| 149 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.48256344 |
| 150 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.48248707 |
| 151 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.47884657 |
| 152 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.47548501 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.46086567 |
| 2 | MP0005360_urolithiasis | 6.80612750 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.69305873 |
| 4 | MP0005365_abnormal_bile_salt | 5.68141847 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.45133918 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 3.84979005 |
| 7 | MP0010329_abnormal_lipoprotein_level | 3.60222465 |
| 8 | MP0003252_abnormal_bile_duct | 3.44499539 |
| 9 | MP0009840_abnormal_foam_cell | 3.34648096 |
| 10 | MP0008260_abnormal_autophagy | 2.75311252 |
| 11 | MP0003191_abnormal_cellular_cholesterol | 2.74925680 |
| 12 | MP0005083_abnormal_biliary_tract | 2.72719568 |
| 13 | MP0005332_abnormal_amino_acid | 2.50359866 |
| 14 | MP0002877_abnormal_melanocyte_morpholog | 2.39240141 |
| 15 | MP0003195_calcinosis | 2.32867882 |
| 16 | MP0001666_abnormal_nutrient_absorption | 2.28118154 |
| 17 | MP0000609_abnormal_liver_physiology | 2.22657819 |
| 18 | MP0003828_pulmonary_edema | 2.21414634 |
| 19 | MP0000858_altered_metastatic_potential | 2.14764202 |
| 20 | MP0002118_abnormal_lipid_homeostasis | 2.13943015 |
| 21 | MP0003566_abnormal_cell_adhesion | 2.09630263 |
| 22 | MP0002138_abnormal_hepatobiliary_system | 1.99330765 |
| 23 | MP0004019_abnormal_vitamin_homeostasis | 1.90683587 |
| 24 | MP0005319_abnormal_enzyme/_coenzyme | 1.88721930 |
| 25 | MP0001764_abnormal_homeostasis | 1.78152330 |
| 26 | MP0003172_abnormal_lysosome_physiology | 1.67980068 |
| 27 | MP0002148_abnormal_hypersensitivity_rea | 1.62797327 |
| 28 | MP0005000_abnormal_immune_tolerance | 1.62403831 |
| 29 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.60516911 |
| 30 | MP0003868_abnormal_feces_composition | 1.58728571 |
| 31 | MP0003436_decreased_susceptibility_to | 1.56673069 |
| 32 | MP0002723_abnormal_immune_serum | 1.52197225 |
| 33 | MP0002452_abnormal_antigen_presenting | 1.52067082 |
| 34 | MP0002420_abnormal_adaptive_immunity | 1.49413107 |
| 35 | MP0001819_abnormal_immune_cell | 1.48583564 |
| 36 | MP0003453_abnormal_keratinocyte_physiol | 1.48370680 |
| 37 | MP0003186_abnormal_redox_activity | 1.46238877 |
| 38 | MP0003656_abnormal_erythrocyte_physiolo | 1.45128390 |
| 39 | MP0003011_delayed_dark_adaptation | 1.42157430 |
| 40 | MP0001851_eye_inflammation | 1.42155494 |
| 41 | MP0000465_gastrointestinal_hemorrhage | 1.41080262 |
| 42 | MP0009697_abnormal_copulation | 1.37664551 |
| 43 | MP0005670_abnormal_white_adipose | 1.37167350 |
| 44 | MP0009764_decreased_sensitivity_to | 1.37015570 |
| 45 | MP0009278_abnormal_bone_marrow | 1.36845772 |
| 46 | MP0002405_respiratory_system_inflammati | 1.36210709 |
| 47 | MP0005387_immune_system_phenotype | 1.35233871 |
| 48 | MP0004381_abnormal_hair_follicle | 1.31865256 |
| 49 | MP0005451_abnormal_body_composition | 1.31610486 |
| 50 | MP0003705_abnormal_hypodermis_morpholog | 1.30568773 |
| 51 | MP0001545_abnormal_hematopoietic_system | 1.28878122 |
| 52 | MP0005397_hematopoietic_system_phenotyp | 1.28878122 |
| 53 | MP0009643_abnormal_urine_homeostasis | 1.23847721 |
| 54 | MP0000598_abnormal_liver_morphology | 1.23380414 |
| 55 | MP0000604_amyloidosis | 1.20898219 |
| 56 | MP0008469_abnormal_protein_level | 1.20343897 |
| 57 | MP0009763_increased_sensitivity_to | 1.19922591 |
| 58 | MP0005076_abnormal_cell_differentiation | 1.19893250 |
| 59 | MP0002396_abnormal_hematopoietic_system | 1.18891711 |
| 60 | MP0005375_adipose_tissue_phenotype | 1.17859968 |
| 61 | MP0003724_increased_susceptibility_to | 1.16300238 |
| 62 | MP0002254_reproductive_system_inflammat | 1.15212187 |
| 63 | MP0005464_abnormal_platelet_physiology | 1.14438197 |
| 64 | MP0002398_abnormal_bone_marrow | 1.13614654 |
| 65 | MP0001915_intracranial_hemorrhage | 1.11670067 |
| 66 | MP0000716_abnormal_immune_system | 1.09965876 |
| 67 | MP0002998_abnormal_bone_remodeling | 1.06819694 |
| 68 | MP0003448_altered_tumor_morphology | 1.06677826 |
| 69 | MP0002971_abnormal_brown_adipose | 1.06260190 |
| 70 | MP0002722_abnormal_immune_system | 1.05841931 |
| 71 | MP0004130_abnormal_muscle_cell | 1.05257745 |
| 72 | MP0005671_abnormal_response_to | 1.04204721 |
| 73 | MP0001849_ear_inflammation | 1.03911779 |
| 74 | MP0005647_abnormal_sex_gland | 1.02250659 |
| 75 | MP0002060_abnormal_skin_morphology | 1.01991070 |
| 76 | MP0005409_darkened_coat_color | 1.01239175 |
| 77 | MP0009333_abnormal_splenocyte_physiolog | 1.00666343 |
| 78 | MP0003183_abnormal_peptide_metabolism | 0.99803939 |
| 79 | MP0002429_abnormal_blood_cell | 0.99652423 |
| 80 | MP0010155_abnormal_intestine_physiology | 0.99629692 |
| 81 | MP0000689_abnormal_spleen_morphology | 0.97894838 |
| 82 | MP0010234_abnormal_vibrissa_follicle | 0.96612847 |
| 83 | MP0003091_abnormal_cell_migration | 0.95816907 |
| 84 | MP0002837_dystrophic_cardiac_calcinosis | 0.94443810 |
| 85 | MP0001853_heart_inflammation | 0.94179021 |
| 86 | MP0002796_impaired_skin_barrier | 0.93558690 |
| 87 | MP0005334_abnormal_fat_pad | 0.93453289 |
| 88 | MP0009642_abnormal_blood_homeostasis | 0.91945172 |
| 89 | MP0003303_peritoneal_inflammation | 0.90999518 |
| 90 | MP0002419_abnormal_innate_immunity | 0.90559152 |
| 91 | MP0009785_altered_susceptibility_to | 0.89640379 |
| 92 | MP0010352_gastrointestinal_tract_polyps | 0.87975387 |
| 93 | MP0001216_abnormal_epidermal_layer | 0.86976458 |
| 94 | MP0004808_abnormal_hematopoietic_stem | 0.86871591 |
| 95 | MP0005058_abnormal_lysosome_morphology | 0.85032212 |
| 96 | MP0006036_abnormal_mitochondrial_physio | 0.84244556 |
| 97 | MP0006054_spinal_hemorrhage | 0.83606927 |
| 98 | MP0005636_abnormal_mineral_homeostasis | 0.83452564 |
| 99 | MP0005376_homeostasis/metabolism_phenot | 0.83446644 |
| 100 | MP0003075_altered_response_to | 0.83238429 |
| 101 | MP0009765_abnormal_xenobiotic_induced | 0.82604540 |
| 102 | MP0010368_abnormal_lymphatic_system | 0.81132064 |
| 103 | MP0005535_abnormal_body_temperature | 0.80495653 |
| 104 | MP0005666_abnormal_adipose_tissue | 0.79804837 |
| 105 | MP0003690_abnormal_glial_cell | 0.79791189 |
| 106 | MP0002078_abnormal_glucose_homeostasis | 0.78187510 |
| 107 | MP0005390_skeleton_phenotype | 0.77876190 |
| 108 | MP0002876_abnormal_thyroid_physiology | 0.75377137 |
| 109 | MP0003763_abnormal_thymus_physiology | 0.75222607 |
| 110 | MP0005025_abnormal_response_to | 0.75140343 |
| 111 | MP0005408_hypopigmentation | 0.72694821 |
| 112 | MP0001845_abnormal_inflammatory_respons | 0.72145238 |
| 113 | MP0001533_abnormal_skeleton_physiology | 0.70211271 |
| 114 | MP0001835_abnormal_antigen_presentation | 0.68206743 |
| 115 | MP0004782_abnormal_surfactant_physiolog | 0.67575202 |
| 116 | MP0005084_abnormal_gallbladder_morpholo | 0.66908052 |
| 117 | MP0005448_abnormal_energy_balance | 0.66711111 |
| 118 | MP0001661_extended_life_span | 0.66385509 |
| 119 | MP0009115_abnormal_fat_cell | 0.64865120 |
| 120 | MP0001756_abnormal_urination | 0.62485233 |
| 121 | MP0006082_CNS_inflammation | 0.61868662 |
| 122 | MP0000685_abnormal_immune_system | 0.61349168 |
| 123 | MP0005166_decreased_susceptibility_to | 0.60904175 |
| 124 | MP0004883_abnormal_blood_vessel | 0.60594212 |
| 125 | MP0000343_altered_response_to | 0.59036726 |
| 126 | MP0003300_gastrointestinal_ulcer | 0.58762938 |
| 127 | MP0003638_abnormal_response/metabolism_ | 0.58465208 |
| 128 | MP0005167_abnormal_blood-brain_barrier | 0.58203597 |
| 129 | MP0005220_abnormal_exocrine_pancreas | 0.57932993 |
| 130 | MP0005164_abnormal_response_to | 0.56802447 |
| 131 | MP0003329_amyloid_beta_deposits | 0.56405736 |
| 132 | MP0002970_abnormal_white_adipose | 0.54424306 |
| 133 | MP0000249_abnormal_blood_vessel | 0.54001292 |
| 134 | MP0002136_abnormal_kidney_physiology | 0.53759122 |
| 135 | MP0005266_abnormal_metabolism | 0.53644381 |
| 136 | MP0000639_abnormal_adrenal_gland | 0.52442693 |
| 137 | MP0009053_abnormal_anal_canal | 0.50864254 |
| 138 | MP0008873_increased_physiological_sensi | 0.49420020 |
| 139 | MP0002928_abnormal_bile_duct | 0.48672376 |
| 140 | MP0004947_skin_inflammation | 0.45906817 |
| 141 | MP0004185_abnormal_adipocyte_glucose | 0.45878297 |
| 142 | MP0001881_abnormal_mammary_gland | 0.45547006 |
| 143 | MP0008874_decreased_physiological_sensi | 0.43746268 |
| 144 | MP0005023_abnormal_wound_healing | 0.43287866 |
| 145 | MP0006035_abnormal_mitochondrial_morpho | 0.40676239 |
| 146 | MP0002132_abnormal_respiratory_system | 0.40449002 |
| 147 | MP0001800_abnormal_humoral_immune | 0.39988322 |
| 148 | MP0001790_abnormal_immune_system | 0.38899483 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 7.10740075 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.53001123 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 6.50031585 |
| 4 | Prolonged partial thromboplastin time (HP:0003645) | 6.16295286 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.00347155 |
| 6 | Xanthomatosis (HP:0000991) | 5.96569474 |
| 7 | Hypobetalipoproteinemia (HP:0003563) | 5.67400840 |
| 8 | Complement deficiency (HP:0004431) | 5.49152816 |
| 9 | Hyperlipoproteinemia (HP:0010980) | 5.14170352 |
| 10 | Joint hemorrhage (HP:0005261) | 5.02193176 |
| 11 | Recurrent abscess formation (HP:0002722) | 4.85622993 |
| 12 | Abnormality of the common coagulation pathway (HP:0010990) | 4.54116831 |
| 13 | Hyperammonemia (HP:0001987) | 4.36979898 |
| 14 | Hypolipoproteinemia (HP:0010981) | 4.36768308 |
| 15 | Abnormality of macrophages (HP:0004311) | 4.31061833 |
| 16 | Epidermoid cyst (HP:0200040) | 4.22481775 |
| 17 | Abnormality of complement system (HP:0005339) | 4.17765291 |
| 18 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.10294085 |
| 19 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.09236440 |
| 20 | Hyperglycinemia (HP:0002154) | 3.98856338 |
| 21 | Ketosis (HP:0001946) | 3.95060324 |
| 22 | Hypoalphalipoproteinemia (HP:0003233) | 3.91500568 |
| 23 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.90730321 |
| 24 | Myositis (HP:0100614) | 3.89129978 |
| 25 | Hyperglycinuria (HP:0003108) | 3.85365455 |
| 26 | Hypoglycemic coma (HP:0001325) | 3.81739305 |
| 27 | Fat malabsorption (HP:0002630) | 3.75909183 |
| 28 | Abnormality of glycine metabolism (HP:0010895) | 3.72615323 |
| 29 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.72615323 |
| 30 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.72211417 |
| 31 | Orchitis (HP:0100796) | 3.66654270 |
| 32 | Abnormality of methionine metabolism (HP:0010901) | 3.64351248 |
| 33 | Systemic lupus erythematosus (HP:0002725) | 3.61594321 |
| 34 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.57576094 |
| 35 | Hypercholesterolemia (HP:0003124) | 3.56833898 |
| 36 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.56555045 |
| 37 | Abnormality of the intrinsic pathway (HP:0010989) | 3.52824208 |
| 38 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.51490460 |
| 39 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.48863750 |
| 40 | Prolonged bleeding time (HP:0003010) | 3.47279327 |
| 41 | Gingivitis (HP:0000230) | 3.18904160 |
| 42 | Conjugated hyperbilirubinemia (HP:0002908) | 3.18726351 |
| 43 | Myocardial infarction (HP:0001658) | 3.16446388 |
| 44 | Hyperbilirubinemia (HP:0002904) | 3.12474035 |
| 45 | Chronic obstructive pulmonary disease (HP:0006510) | 3.12168579 |
| 46 | Obstructive lung disease (HP:0006536) | 3.12168579 |
| 47 | Purpura (HP:0000979) | 3.07627305 |
| 48 | Optic neuritis (HP:0100653) | 3.06635729 |
| 49 | Retrobulbar optic neuritis (HP:0100654) | 3.06635729 |
| 50 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.94423153 |
| 51 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.92324780 |
| 52 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.92324780 |
| 53 | Abnormality of glycolipid metabolism (HP:0010969) | 2.92324780 |
| 54 | Abnormality of nucleobase metabolism (HP:0010932) | 2.89512418 |
| 55 | Steatorrhea (HP:0002570) | 2.86882929 |
| 56 | Urticaria (HP:0001025) | 2.86762921 |
| 57 | Petechiae (HP:0000967) | 2.85051380 |
| 58 | Recurrent skin infections (HP:0001581) | 2.84745116 |
| 59 | Ketoacidosis (HP:0001993) | 2.80374425 |
| 60 | Glomerulonephritis (HP:0000099) | 2.80261079 |
| 61 | Peritonitis (HP:0002586) | 2.79313018 |
| 62 | Abnormality of serum amino acid levels (HP:0003112) | 2.74655827 |
| 63 | Hepatocellular carcinoma (HP:0001402) | 2.73369109 |
| 64 | Gastrointestinal infarctions (HP:0005244) | 2.73339847 |
| 65 | Spontaneous abortion (HP:0005268) | 2.69853310 |
| 66 | Delayed CNS myelination (HP:0002188) | 2.69625208 |
| 67 | Skin nodule (HP:0200036) | 2.68867134 |
| 68 | Gingival bleeding (HP:0000225) | 2.67008874 |
| 69 | Stomatitis (HP:0010280) | 2.66890384 |
| 70 | Spontaneous hematomas (HP:0007420) | 2.65577705 |
| 71 | Mediastinal lymphadenopathy (HP:0100721) | 2.64794550 |
| 72 | Keratoconjunctivitis sicca (HP:0001097) | 2.64075418 |
| 73 | Dicarboxylic aciduria (HP:0003215) | 2.60682444 |
| 74 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.60682444 |
| 75 | Hypochromic microcytic anemia (HP:0004840) | 2.59636318 |
| 76 | Abnormality of purine metabolism (HP:0004352) | 2.55991105 |
| 77 | Menorrhagia (HP:0000132) | 2.54568939 |
| 78 | Amyloidosis (HP:0011034) | 2.53177014 |
| 79 | Acanthocytosis (HP:0001927) | 2.52617462 |
| 80 | Metabolic acidosis (HP:0001942) | 2.52035134 |
| 81 | Hepatosplenomegaly (HP:0001433) | 2.50421437 |
| 82 | Increased IgE level (HP:0003212) | 2.46763635 |
| 83 | Esophageal varix (HP:0002040) | 2.39809496 |
| 84 | Mitral stenosis (HP:0001718) | 2.37168843 |
| 85 | Vascular calcification (HP:0004934) | 2.35851461 |
| 86 | Recurrent fungal infections (HP:0002841) | 2.32817757 |
| 87 | Vertebral compression fractures (HP:0002953) | 2.32810554 |
| 88 | Spastic diplegia (HP:0001264) | 2.31975910 |
| 89 | Abnormal gallbladder morphology (HP:0012437) | 2.31752607 |
| 90 | Lethargy (HP:0001254) | 2.31682971 |
| 91 | Cellulitis (HP:0100658) | 2.30558629 |
| 92 | Keratoconjunctivitis (HP:0001096) | 2.29053552 |
| 93 | Episodic fever (HP:0001954) | 2.28910346 |
| 94 | Pustule (HP:0200039) | 2.28162223 |
| 95 | Cholelithiasis (HP:0001081) | 2.28029160 |
| 96 | Hypoglycemic seizures (HP:0002173) | 2.26518697 |
| 97 | Thick nail (HP:0001805) | 2.24416269 |
| 98 | Thrombophlebitis (HP:0004418) | 2.24261505 |
| 99 | Pancreatitis (HP:0001733) | 2.23540469 |
| 100 | Polycythemia (HP:0001901) | 2.22675153 |
| 101 | Increased cerebral lipofuscin (HP:0011813) | 2.22431140 |
| 102 | Cholecystitis (HP:0001082) | 2.21535095 |
| 103 | Abnormal gallbladder physiology (HP:0012438) | 2.21535095 |
| 104 | Dysostosis multiplex (HP:0000943) | 2.20958246 |
| 105 | Upper motor neuron abnormality (HP:0002127) | 2.18599930 |
| 106 | Periodontitis (HP:0000704) | 2.16047954 |
| 107 | Hemorrhage of the eye (HP:0011885) | 2.15907297 |
| 108 | Arterial thrombosis (HP:0004420) | 2.15607381 |
| 109 | Cheilitis (HP:0100825) | 2.13753091 |
| 110 | Meningitis (HP:0001287) | 2.13657326 |
| 111 | Hypertriglyceridemia (HP:0002155) | 2.13577645 |
| 112 | Irritability (HP:0000737) | 2.13107356 |
| 113 | Abnormality of iron homeostasis (HP:0011031) | 2.12409804 |
| 114 | Cardiovascular calcification (HP:0011915) | 2.10104614 |
| 115 | Polygenic inheritance (HP:0010982) | 2.08916013 |
| 116 | Nephritis (HP:0000123) | 2.08496672 |
| 117 | Abnormal platelet function (HP:0011869) | 2.08270729 |
| 118 | Impaired platelet aggregation (HP:0003540) | 2.08270729 |
| 119 | Increased serum ferritin (HP:0003281) | 2.07361108 |
| 120 | Cerebral edema (HP:0002181) | 2.07184172 |
| 121 | Neonatal onset (HP:0003623) | 2.07009538 |
| 122 | Generalized aminoaciduria (HP:0002909) | 2.05475518 |
| 123 | Sensorimotor neuropathy (HP:0007141) | 2.04204190 |
| 124 | Hydroxyprolinuria (HP:0003080) | 2.03276379 |
| 125 | Abnormality of proline metabolism (HP:0010907) | 2.03276379 |
| 126 | Anorexia (HP:0002039) | 2.03137783 |
| 127 | Eczematoid dermatitis (HP:0000976) | 2.02520675 |
| 128 | Vacuolated lymphocytes (HP:0001922) | 2.02132916 |
| 129 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.01812820 |
| 130 | Loss of speech (HP:0002371) | 2.01578780 |
| 131 | Gastrointestinal inflammation (HP:0004386) | 2.01406122 |
| 132 | Late onset (HP:0003584) | 2.01092270 |
| 133 | Skin ulcer (HP:0200042) | 2.01036594 |
| 134 | Increased connective tissue (HP:0009025) | 1.99866579 |
| 135 | Abnormality of the peritoneum (HP:0002585) | 1.99758664 |
| 136 | Glomerulopathy (HP:0100820) | 1.99667932 |
| 137 | Poikilocytosis (HP:0004447) | 1.99245332 |
| 138 | Hypochromic anemia (HP:0001931) | 1.99231376 |
| 139 | Subacute progressive viral hepatitis (HP:0006572) | 1.98763853 |
| 140 | Axonal loss (HP:0003447) | 1.98017978 |
| 141 | Inflammation of the large intestine (HP:0002037) | 1.97773977 |
| 142 | Pulmonary embolism (HP:0002204) | 1.96499230 |
| 143 | Brushfield spots (HP:0001088) | 1.95806570 |
| 144 | Pathologic fracture (HP:0002756) | 1.95731439 |
| 145 | Gout (HP:0001997) | 1.95573772 |
| 146 | Vomiting (HP:0002013) | 1.93403594 |
| 147 | Malnutrition (HP:0004395) | 1.93213871 |
| 148 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.93117811 |
| 149 | Encephalitis (HP:0002383) | 1.92142786 |
| 150 | Chest pain (HP:0100749) | 1.88832105 |
| 151 | Epistaxis (HP:0000421) | 1.88560467 |
| 152 | Bruising susceptibility (HP:0000978) | 1.88363534 |
| 153 | Interstitial pulmonary disease (HP:0006530) | 1.87538829 |
| 154 | Gangrene (HP:0100758) | 1.87300567 |
| 155 | Abnormal cartilage morphology (HP:0002763) | 1.87024334 |
| 156 | Milia (HP:0001056) | 1.86694944 |
| 157 | Nausea (HP:0002018) | 1.86558279 |
| 158 | Abnormality of the gallbladder (HP:0005264) | 1.84385500 |
| 159 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.84119135 |
| 160 | Increased mean platelet volume (HP:0011877) | 1.83759655 |
| 161 | Recurrent bacterial skin infections (HP:0005406) | 1.83437444 |
| 162 | Enlarged kidneys (HP:0000105) | 1.82066551 |
| 163 | Metaphyseal cupping (HP:0003021) | 1.82052203 |
| 164 | Elevated hepatic transaminases (HP:0002910) | 1.81284044 |
| 165 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.81046267 |
| 166 | Recurrent cutaneous fungal infections (HP:0011370) | 1.81046267 |
| 167 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.80816174 |
| 168 | Vasculitis (HP:0002633) | 1.80116747 |
| 169 | Toxemia of pregnancy (HP:0100603) | 1.78247773 |
| 170 | Opisthotonus (HP:0002179) | 1.78169818 |
| 171 | Abnormal platelet volume (HP:0011876) | 1.77462619 |
| 172 | Osteomyelitis (HP:0002754) | 1.76990184 |
| 173 | Abnormal blistering of the skin (HP:0008066) | 1.74226596 |
| 174 | Fatigue (HP:0012378) | 1.72803011 |
| 175 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.70603235 |
| 176 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.70603235 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 5.67728032 |
| 2 | ERN1 | 4.59552762 |
| 3 | SIK1 | 3.83676923 |
| 4 | RIPK4 | 3.64622221 |
| 5 | FGFR4 | 3.49682449 |
| 6 | TAOK3 | 2.90361597 |
| 7 | TRIB3 | 2.88081313 |
| 8 | PKN2 | 2.68039498 |
| 9 | TYK2 | 2.20863949 |
| 10 | INSRR | 2.12007123 |
| 11 | CAMK1D | 2.11727716 |
| 12 | MST1R | 2.11108930 |
| 13 | PRPF4B | 1.94081949 |
| 14 | MAP2K3 | 1.92075311 |
| 15 | FLT3 | 1.90753768 |
| 16 | EPHB1 | 1.84748899 |
| 17 | ERBB4 | 1.70172089 |
| 18 | SMG1 | 1.70141922 |
| 19 | FGR | 1.70107121 |
| 20 | PIK3CG | 1.69133419 |
| 21 | KSR2 | 1.68964153 |
| 22 | PTK6 | 1.59058292 |
| 23 | BLK | 1.58157658 |
| 24 | MAPK11 | 1.56823893 |
| 25 | MAP3K2 | 1.53167902 |
| 26 | TBK1 | 1.50661635 |
| 27 | NME2 | 1.49732950 |
| 28 | IRAK4 | 1.47882419 |
| 29 | NEK9 | 1.47880698 |
| 30 | GRK6 | 1.45951802 |
| 31 | MAP2K4 | 1.37632422 |
| 32 | MAP3K14 | 1.37490942 |
| 33 | TAOK1 | 1.36913215 |
| 34 | JAK2 | 1.36392594 |
| 35 | CSK | 1.34670341 |
| 36 | KDR | 1.32556157 |
| 37 | PAK4 | 1.29615422 |
| 38 | MAP3K3 | 1.29573336 |
| 39 | IRAK3 | 1.29244096 |
| 40 | ABL2 | 1.27828856 |
| 41 | PRKAA2 | 1.26956171 |
| 42 | MAP4K1 | 1.25289083 |
| 43 | TGFBR2 | 1.24145157 |
| 44 | JAK1 | 1.22726783 |
| 45 | YES1 | 1.22289206 |
| 46 | CDK12 | 1.19624845 |
| 47 | RIPK1 | 1.16384154 |
| 48 | CAMK1G | 1.14628214 |
| 49 | FRK | 1.10686570 |
| 50 | DAPK2 | 1.08225392 |
| 51 | TESK2 | 1.07551447 |
| 52 | BTK | 1.04166771 |
| 53 | CSF1R | 1.01692020 |
| 54 | MAPK4 | 1.00574765 |
| 55 | EPHA2 | 0.99968823 |
| 56 | MAP3K11 | 0.98654391 |
| 57 | MOS | 0.97450124 |
| 58 | MAP3K10 | 0.90719371 |
| 59 | ICK | 0.89730752 |
| 60 | CDK6 | 0.87357632 |
| 61 | ZAP70 | 0.86661658 |
| 62 | MARK3 | 0.86595160 |
| 63 | FGFR3 | 0.84842832 |
| 64 | IKBKE | 0.84098254 |
| 65 | KIT | 0.83753917 |
| 66 | ARAF | 0.83220595 |
| 67 | TNK2 | 0.79930106 |
| 68 | FGFR2 | 0.79451779 |
| 69 | EPHA3 | 0.79306099 |
| 70 | RAF1 | 0.78481030 |
| 71 | MAP3K7 | 0.77453619 |
| 72 | MAP3K8 | 0.77371397 |
| 73 | PTK2B | 0.77206096 |
| 74 | LATS1 | 0.76798934 |
| 75 | IRAK2 | 0.75340193 |
| 76 | TEC | 0.74129681 |
| 77 | TIE1 | 0.71530313 |
| 78 | BMPR2 | 0.71320781 |
| 79 | PRKACG | 0.68091330 |
| 80 | IRAK1 | 0.67092787 |
| 81 | LRRK2 | 0.66657246 |
| 82 | MAP3K6 | 0.63430733 |
| 83 | LCK | 0.62598048 |
| 84 | PRKCZ | 0.61497923 |
| 85 | EIF2AK1 | 0.60620610 |
| 86 | MAP2K6 | 0.60618904 |
| 87 | PRKD2 | 0.60334939 |
| 88 | PDPK1 | 0.58305427 |
| 89 | SIK3 | 0.58218657 |
| 90 | JAK3 | 0.57396258 |
| 91 | HCK | 0.57077936 |
| 92 | STK10 | 0.56960805 |
| 93 | PTK2 | 0.56931952 |
| 94 | MAP3K13 | 0.55842325 |
| 95 | ERBB2 | 0.55109989 |
| 96 | MAPK12 | 0.54976404 |
| 97 | GSK3A | 0.53943623 |
| 98 | MET | 0.53569803 |
| 99 | KSR1 | 0.52734206 |
| 100 | STK38 | 0.51971164 |
| 101 | PRKAA1 | 0.50025731 |
| 102 | EEF2K | 0.49878200 |
| 103 | MARK2 | 0.49778160 |
| 104 | MAPKAPK2 | 0.49713821 |
| 105 | ITK | 0.49434117 |
| 106 | IGF1R | 0.49049555 |
| 107 | CDK4 | 0.47560576 |
| 108 | SGK3 | 0.47381059 |
| 109 | PINK1 | 0.46737196 |
| 110 | PDGFRB | 0.46545907 |
| 111 | PRKG2 | 0.46467146 |
| 112 | IKBKB | 0.46030793 |
| 113 | MAP3K5 | 0.45624052 |
| 114 | LYN | 0.45356446 |
| 115 | SYK | 0.45210535 |
| 116 | PDK1 | 0.44914032 |
| 117 | DYRK1B | 0.43857454 |
| 118 | RET | 0.43843188 |
| 119 | EGFR | 0.42690714 |
| 120 | TRPM7 | 0.42210560 |
| 121 | PDGFRA | 0.40595592 |
| 122 | PRKCQ | 0.39505981 |
| 123 | MYLK | 0.38256232 |
| 124 | FYN | 0.37984656 |
| 125 | FES | 0.36005940 |
| 126 | RPS6KA4 | 0.35617155 |
| 127 | ABL1 | 0.34975348 |
| 128 | PBK | 0.33829884 |
| 129 | PIM1 | 0.33755160 |
| 130 | BMX | 0.33655441 |
| 131 | MAP3K1 | 0.33331564 |
| 132 | TAOK2 | 0.33220218 |
| 133 | MATK | 0.31073851 |
| 134 | GRK1 | 0.30246609 |
| 135 | PRKCD | 0.28858312 |
| 136 | CHUK | 0.28445235 |
| 137 | MAP2K1 | 0.28115287 |
| 138 | TTN | 0.25726983 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.37153857 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.48308973 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.29791328 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.08989982 |
| 5 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.97282726 |
| 6 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.95206425 |
| 7 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.60781282 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.59964157 |
| 9 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.55985803 |
| 10 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.54006687 |
| 11 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.45210239 |
| 12 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.38905217 |
| 13 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.36833691 |
| 14 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.30410329 |
| 15 | Peroxisome_Homo sapiens_hsa04146 | 2.09909278 |
| 16 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.08653303 |
| 17 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.06627486 |
| 18 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.03181030 |
| 19 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.03117427 |
| 20 | Histidine metabolism_Homo sapiens_hsa00340 | 1.96989033 |
| 21 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.95013699 |
| 22 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.94781625 |
| 23 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.93705216 |
| 24 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.84682816 |
| 25 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.82627816 |
| 26 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.81117014 |
| 27 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.77115231 |
| 28 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.75903107 |
| 29 | Tuberculosis_Homo sapiens_hsa05152 | 1.75855033 |
| 30 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.71094774 |
| 31 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.70365675 |
| 32 | Retinol metabolism_Homo sapiens_hsa00830 | 1.63140907 |
| 33 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.60935290 |
| 34 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.58918404 |
| 35 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.58775256 |
| 36 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.53889828 |
| 37 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.53393561 |
| 38 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.53377343 |
| 39 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.53370855 |
| 40 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.50159254 |
| 41 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.49154062 |
| 42 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.48045397 |
| 43 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.41569230 |
| 44 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.40504423 |
| 45 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.39111443 |
| 46 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.38231188 |
| 47 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.35516324 |
| 48 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.35433038 |
| 49 | Bile secretion_Homo sapiens_hsa04976 | 1.32662899 |
| 50 | Shigellosis_Homo sapiens_hsa05131 | 1.32654062 |
| 51 | Phagosome_Homo sapiens_hsa04145 | 1.32259928 |
| 52 | Platelet activation_Homo sapiens_hsa04611 | 1.31015939 |
| 53 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.30475443 |
| 54 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.30450491 |
| 55 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.29104011 |
| 56 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.28551295 |
| 57 | ABC transporters_Homo sapiens_hsa02010 | 1.26233693 |
| 58 | Carbon metabolism_Homo sapiens_hsa01200 | 1.25413935 |
| 59 | * Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.24178124 |
| 60 | Salmonella infection_Homo sapiens_hsa05132 | 1.23472411 |
| 61 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.23266874 |
| 62 | Measles_Homo sapiens_hsa05162 | 1.23160909 |
| 63 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.19940095 |
| 64 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.18977690 |
| 65 | Influenza A_Homo sapiens_hsa05164 | 1.13987978 |
| 66 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.13184081 |
| 67 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.12043356 |
| 68 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.09775458 |
| 69 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.09075140 |
| 70 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.05602775 |
| 71 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.04632305 |
| 72 | Apoptosis_Homo sapiens_hsa04210 | 1.03951414 |
| 73 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.02058621 |
| 74 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.01992134 |
| 75 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.00882421 |
| 76 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.96780779 |
| 77 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.96500101 |
| 78 | Hepatitis B_Homo sapiens_hsa05161 | 0.94083704 |
| 79 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.91493618 |
| 80 | Sulfur relay system_Homo sapiens_hsa04122 | 0.91164380 |
| 81 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.89816703 |
| 82 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.88376188 |
| 83 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.87626457 |
| 84 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.85641165 |
| 85 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.84607924 |
| 86 | Thyroid cancer_Homo sapiens_hsa05216 | 0.84110187 |
| 87 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.82731211 |
| 88 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.82023702 |
| 89 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.81798057 |
| 90 | Bladder cancer_Homo sapiens_hsa05219 | 0.81441867 |
| 91 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.81428195 |
| 92 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.81297111 |
| 93 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.80217384 |
| 94 | Lysine degradation_Homo sapiens_hsa00310 | 0.79766071 |
| 95 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.78726761 |
| 96 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.78722068 |
| 97 | Endocytosis_Homo sapiens_hsa04144 | 0.78243480 |
| 98 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.77396898 |
| 99 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.76018904 |
| 100 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.72115389 |
| 101 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.71232807 |
| 102 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.70776915 |
| 103 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.68709592 |
| 104 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.68069202 |
| 105 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.67479291 |
| 106 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.67054378 |
| 107 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.66778230 |
| 108 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.66460010 |
| 109 | Focal adhesion_Homo sapiens_hsa04510 | 0.65950381 |
| 110 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.65554384 |
| 111 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.64432666 |
| 112 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.64296438 |
| 113 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.61374733 |
| 114 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.61201470 |
| 115 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.60424611 |
| 116 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.59182381 |
| 117 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.55645276 |
| 118 | Viral myocarditis_Homo sapiens_hsa05416 | 0.51412286 |
| 119 | Endometrial cancer_Homo sapiens_hsa05213 | 0.50785532 |
| 120 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.49587788 |
| 121 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.47263306 |
| 122 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.47236580 |
| 123 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.46072629 |
| 124 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.45409563 |
| 125 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.45014442 |
| 126 | Adherens junction_Homo sapiens_hsa04520 | 0.43808139 |
| 127 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.40393052 |
| 128 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.39386092 |
| 129 | Glioma_Homo sapiens_hsa05214 | 0.38217332 |
| 130 | Galactose metabolism_Homo sapiens_hsa00052 | 0.35115874 |
| 131 | Prion diseases_Homo sapiens_hsa05020 | 0.34377567 |
| 132 | * Insulin resistance_Homo sapiens_hsa04931 | 0.32292189 |
| 133 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.30686612 |
| 134 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.16223095 |
| 135 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.15331960 |
| 136 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.14836660 |
| 137 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.13440125 |
| 138 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.11870780 |
| 139 | Pertussis_Homo sapiens_hsa05133 | 0.08563295 |
| 140 | Leishmaniasis_Homo sapiens_hsa05140 | 0.06022323 |
| 141 | * Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.01528305 |
| 142 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | -0.1482428 |
| 143 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1254573 |
| 144 | Osteoclast differentiation_Homo sapiens_hsa04380 | -0.1231295 |
| 145 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | -0.1112339 |
| 146 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.1063993 |
| 147 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.0993830 |
| 148 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.0759889 |
| 149 | Hepatitis C_Homo sapiens_hsa05160 | -0.0679277 |
| 150 | Malaria_Homo sapiens_hsa05144 | -0.0673883 |
| 151 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | -0.0613266 |
| 152 | Amoebiasis_Homo sapiens_hsa05146 | -0.0537130 |
| 153 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | -0.0491616 |
| 154 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.0474567 |
| 155 | * Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0460089 |
| 156 | Other glycan degradation_Homo sapiens_hsa00511 | -0.0311883 |
| 157 | Legionellosis_Homo sapiens_hsa05134 | -0.0279749 |
| 158 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0279202 |
| 159 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0187411 |
| 160 | Lysosome_Homo sapiens_hsa04142 | -0.0180956 |

